NRBO insider transaction filings
NeuroBo Pharmaceuticals, Inc. — 10 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-09-20. Screen NRBO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for NRBO between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — NeuroBo Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-09-20 | 4 | DONG-A ST CO., LTD — 10% owner | Sale (S): 407 @ $3.75 · Purchase (P): 2,544,530 (derivative) · Purchase (P): 3,816,795 (derivative) | EDGAR |
| 2024-08-13 | 4 | Kim Hyung Heon — CEO & President, Director | Tax withholding (F): 11,467 @ $3.60 | EDGAR |
| 2024-07-10 | 4/A | DONG-A ST CO., LTD — 10% owner | Purchase (P): 2,544,530 @ $3.93 | EDGAR |
| 2024-06-25 | 4 | DONG-A ST CO., LTD — 10% owner | Purchase (P): 2,544,530 @ $3.13 | EDGAR |
| 2024-06-07 | 4 | Salsbury Michael — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-06-07 | 4 | Tursi James Patrick — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-06-07 | 4 | GROVES JASON L — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-06-07 | 4 | Glickman Mark A — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-06-07 | 4 | KOVEN ANDREW I — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-06-07 | 4 | STRICKLAND D GORDON — Director | Grant/award (A): 5,051 @ $0 | EDGAR |
Recent 8-K events — NeuroBo Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NRBO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →